Kitsap Provider Resources

Health Advisory: State Mask Requirement Remains in Place for Healthcare Settings

Actions Requested Be aware, Washington’s COVID-19 public health emergency proclamations ended Oct. 31, 2022. However, mask requirements remain in place statewide for: Healthcare settings Long-term care settings Correctional facilities where Centers for Disease Control and Prevention (CDC) COVID-19 community level is medium or high Be aware, Washington Secretary of Health’s face covering order is not subject to the Health Advisory: State Mask Requirement Remains in Place for Healthcare Settings

Kitsap Respiratory Illness Report: October 23 – October 29, 2022

Click here to access week 43 of the Kitsap Respiratory Illness Report: 10.23.2022 – 10.29.2022.

Health Advisory: 2022–2023 Respiratory Illness Season Surveillance, Influenza Testing & Treatment

Actions Requested Recommend everyone 6 months or older get influenza vaccine, unless contraindicated. Vaccinate against influenza at every opportunity. Know the optimal times to give influenza vaccine. See our Influenza page to access local, state and national influenza information. Review influenza testing and treatment guidelines. Report influenza deaths and outbreaks in congregate settings by calling Health Advisory: 2022–2023 Respiratory Illness Season Surveillance, Influenza Testing & Treatment

Health Advisory: Outbreak of Ebola Virus Disease (Sudan ebolavirus) in Uganda

Actions Requested Be aware of an ongoing outbreak of Ebola Virus Disease (EVD, Sudan ebolavirus) in Uganda since September 2022. As of October 24, 2022, the Uganda Ministry of Health reported 95 confirmed cases in eight districts in Uganda, including the capital city. Counsel patients planning travel to Uganda about EVD and health protection measures. Be Health Advisory: Outbreak of Ebola Virus Disease (Sudan ebolavirus) in Uganda

Health Advisory: Updated bivalent mRNA COVID-19 boosters available to children 5 years or older; Novavax received FDA authorization

October 24, 2022 Actions Requested Be aware, the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and Western States Scientific Safety Review Workgroup approved an age expansion for updated COVID-19 vaccine bivalent booster dose at least 2 months after their primary series or last booster dose. The expansion allows children: 5–11 years old to get 1 booster dose Health Advisory: Updated bivalent mRNA COVID-19 boosters available to children 5 years or older; Novavax received FDA authorization

Health Advisory: Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68

Actions Requested Review the Acute Flaccid Myelitis (AFM) in 2022 Situation Update below from the Washington State Department of Health. Report possible cases of AFM to Kitsap Public Health as soon as suspected by calling (360) 728-2235. Situation Update Acute Flaccid Myelitis in 2022 – Summary Since the end of August 2022, CDC sentinel surveillance Health Advisory: Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68

Kitsap Respiratory Illness Report: October 16 – October 22, 2022

Click here to access week 42 of the Kitsap Respiratory Illness Report: 10.16.2022 – 10.22.2022.

Health Advisory: COVID-19 and Monkeypox Update for Providers

syringe in vial

Actions Requested COVID-19 Be aware, emergency use of the Novavax COVID-19 vaccine was authorized as a two-dose primary series in individuals 12 through 17 years of age on August 19, 2022 by the U.S. Food & Drug Administration. They analyzed the vaccine in this age group and found it to be safe and effective. The Health Advisory: COVID-19 and Monkeypox Update for Providers

Kitsap Respiratory Illness Report: August 14 – September 10, 2022

Click here to access weeks 33-36 of the Kitsap Respiratory Illness Report: 8.14.2022 – 9.10.2022.

Kitsap Respiratory Illness Report: July 17 – August 13, 2022

Click here to access weeks 29-32 of the Kitsap Respiratory Illness Report: 07.17.2022 – 08.13.2022.